Tune-401: a first-in-class epigenetic silencer of HBV demonstrates deep and durable antiviral activity in the phase 1b/2a proof of concept Tune-401-001 study

Conference Reports for NATAP

EASL - European Association
for the Study of the Liver
Barcelona, Spain
May 27-30, 2026


Tune-401: a first-in-class epigenetic silencer of HBV demonstrates deep and durable antiviral activity in the phase 1b/2a proof of concept Tune-401-001 study

	EASL 2026 May 26-30 Barcelona